Researchers from NYU Grossman School of Medicine found people previously infected with the SARS-CoV-2 coronavirus may produce enough antibodies against COVID-19 after one dose of the Pfizer–BioNTech COVID-19 vaccine that is equal to or higher than people not previously infected have after two vaccinations.
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia
High hesitancy even seen among Black health care workers, survey finds
Rates for hospitalized patients consistently higher compared with 2019
And, more than half of pregnant women would also accept a COVID-19 vaccine for themselves
Risks for hospitalization, intensive care unit admission, and death increased sharply with higher BMIs
The United States is now delivering an average of 2.17 million doses of COVID-19 vaccines a day